James Ho, MD
Adult Reconstructive Orthopaedic Surgery · Medford, ORNPI 1396069811
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $14,534 of the $15,437 with a category attached, or 94.2%. Johnson & Johnson accounts for 92.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $15,017 and has fallen 99.3% since, to $101 in 2025.
Across 33 payments — averaging $467.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$14K
- Zimmer Biomet$1K
- Smith+Nephew$51
- Gilead$30
- Stryker$13
What the payments were for
- Travel & lodging$14,53494%
- Food & beverage$9026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 18 | $14,252 |
| Zimmer Biomet | 11 | $1,090 |
| Smith+Nephew | 2 | $51 |
| Gilead | 1 | $30 |
| Stryker | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORAIL$13,715
- Taperloc$597
- Persona Revision$169
How this compares
$15,437 in reported general payments places this provider in the 75th percentile of 20 adult reconstructive orthopaedic surgery providers in Oregon.
See all adult reconstructive orthopaedic surgery providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 32 | $246 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $224 |
| Celecoxib | 15 | $179 |
| Cephalexin | 43 | $174 |
| Gabapentin | 14 | $135 |
| Methylprednisolone | 17 | $100 |
| Cyclobenzaprine Hcl | 20 | $94 |
| Ondansetron Hcl | 14 | $87 |
| Tramadol Hcl | 22 | $79 |
| Meloxicam | 19 | $64 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Medford
- Jeffrey JancuskaMedford$6K
- Ryland KaganPortland$154K
- Thomas HuffPortland$95K
- James VanhorneGrants Pass$42K
- Gustav FischerPortland$24K
- Lily WoodPortland$14K
- Daniel CowleyGrants Pass$12K
- Jessica PhillipsBeaverton$12K
- Mary SkrzynskiBend$10K
- Mark MildrenEugene$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.